Select Publications

Conference Abstracts

Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin AH; Dillon JF; Read P; Gane ED; Dore GJ, 2017, 'EFFICACY AND SAFETY OF SOFOSBUVIR/VELPATASVIR IN PEOPLE WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT INJECTING DRUG USE: THE SIMPLIFY STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 34 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Marshall AD; Nielsen S; Cunningham EB; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Flisiak R; Foster G; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancorienė L; Jarčuška P; Kåberg M; Makara M; Maimets M; Marinho R; Matičič M; Norris S; Olafsson S; Øvrehus A; Pawlotsky J-M; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J; Network INOHISU, 2017, 'LBP-505 Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe', in Journal of Hepatology, Elsevier, Vol. 66, pp. s95 - s96, http://dx.doi.org/10.1016/s0168-8278(17)30450-6

Kwon AJ; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Estes C; Razavi H; Gray RT; group OBOTHEAPR, 2017, 'O12 Australia could meet the WHO HCV elimination targets if the current rollout of DAA treatment is continued', in Journal of Virus Eradication, Elsevier, Vol. 3, pp. 5, http://dx.doi.org/10.1016/s2055-6640(20)30895-5

Reports

Kwon J; Gray R; Dore G; Grebely J; Guy R; Hajarizadeh B; Cunningham E, 2017, 2017 Estimates and Projections of the Hepatitis C Virus Epidemic in NSW: Summary Report, Sydney: Kirby Institute, UNSW Sydney

Preprints

Shih ST; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, 2022, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, http://dx.doi.org/10.2139/ssrn.4267510

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Group S-CS, 2020, Reduced Hepatitis C Incidence Associated with Rapid Treatment Scale-Up in Australian Prisons: Treatment-as-Prevention in the SToP-C Study, http://dx.doi.org/10.2139/ssrn.3709824

Kwon J; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT, Australia on Track to Achieve Who HCV Elimination Targets Following Rapid Initial DAA Treatment Uptake: A Modelling Study, http://dx.doi.org/10.2139/ssrn.3213670

Santo T; Hickman M; Altice F; Grebely J; Taylor S; Lynch M; Kamenjas A; Marsden J; Tran L; Webb P; Price O; Macdonald C; Montanari L; Royuela L; Busse A; Stone J; da Costa FA; Berk J; Daniels C; Cunningham EB; Vickerman P; Hajarizadeh B; Sabin K; Verster A; Farrell M; Degenhardt L, Global Coverage of Interventions for the Reduction of Injecting Drug Use-Related Harm, and Prevention and Treatment of HIV, Viral Hepatitis and Tuberculosis in Prisons and Other Carceral Settings, http://dx.doi.org/10.2139/ssrn.5217957

Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham EB; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran L; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J, Global, Regional, and Country-Level Coverage of Testing and Treatment for HIV and Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review, http://dx.doi.org/10.2139/ssrn.4402728

Wu H-J; Grebely J; Applegate TL; Kwon JA; Cheng Q; Martinello M; Sheehan Y; Hajarizadeh B; Wiseman V; Cunningham EB; Dore GJ; Lloyd AR; Matthews S; Markus C; Marshall AD; Lafferty L; Kingsland M; Causer LM; Pedrana A; Fontaine G; Taylor N; Clynes L; Murray J; Shih ST; Gray RT; Hepatitis C Point-of-Care Testing Progrm A, Impact And Cost-Effectiveness Of Scaling Up A National Point-Of-Care Hepatitis C Testing And Treatment Program In Australia: A Mathematical Modelling Study, http://dx.doi.org/10.2139/ssrn.7445300

Wu H-J; Shih ST; Applegate TL; Kwon J; Cunningham EB; Grebely J; Gray RT, Impact of Simplified HCV Diagnostic Strategies on the HCV Epidemic Among Men Who Have Sex with Men in Taiwan: A Modelling Study, http://dx.doi.org/10.2139/ssrn.4431789

Shih ST; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon JA; Lloyd AR; Dore GJ; Wiseman V; Grebely J, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, http://dx.doi.org/10.2139/ssrn.4267527

Wu H-J; Applegate TL; Kwon JA; Cunningham EB; Grebely J; Gray RT; Shih ST, The Cost-Effectiveness of Integrating Simplified HCV Testing into HIV Pre-Exposure Prophylaxis (PrEP) and Treatment Services Among Men Who Have Sex with Men in Taiwan, http://dx.doi.org/10.2139/ssrn.4718220


Back to profile page